To determine the in vitro inhibitory effect of experimental antibacterial substances in determinations against bacterial pathogens using MIC.
Ended Awarded Last action
- Contract number
- 75N93021F00001
- Awardee
-
Element Materials Technology Iowa City Inc. UEI GAJDDSFFPD89
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $355,736
Award facts
- Opportunity
-
- A18 Solicitation number
- Contract value 47% obligated
-
- $355,736.00 Current, with exercised options
- $755,736.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Liberty, IA 52317, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$68,264 | |
| Other Administrative Action | $0 | |
| Original award | $424,000 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $755.7K delivery order to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, on September 16, 2021, with completion targeted for September 15, 2022. Under this firm fixed-price contract, JMI Laboratories will determine the in vitro inhibitory effect of experimental antibacterial substances against bacterial pathogens using minimum inhibitory concentration (MIC) testing methodologies. The work will be performed in North Liberty, Iowa. This delivery order was issued under the In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite-delivery/indefinite-quantity contract vehicle and carries no set-aside designation.
JMI Laboratories is a microbiology specialist company registered as a for-profit Subchapter S Corporation that has served as a federal contractor since November 2016, primarily supporting the Department of Health and Human Services agencies including NIAID, the Food and Drug Administration, and the National Institutes of Health. The company has established expertise in conducting antimicrobial resistance research, in vitro screening assessments, and MIC assays that directly support federal efforts to address critical public health challenges related to emerging antimicrobial resistance. This award reflects JMI Laboratories' core capabilities and continued partnership with NIAID on antimicrobial activity research initiatives.
Quick answers
Who was awarded contract 75N93021F00001?
75N93021F00001 was awarded to Element Materials Technology Iowa City Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 16, 2021.
How much is contract 75N93021F00001 worth?
The government has obligated $355,736 on 75N93021F00001. Its potential value, with all options, is $755,736.
Is contract 75N93021F00001 an order under another contract?
Yes. 75N93021F00001 is a delivery order under 75N93019D00011, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93021F00001 competed?
The extent of competition for 75N93021F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award